Objective Previous studies have revealed functional changes within the cerebral hemispheres of patients with SLE; however the ...

A Japanese research team has found a new way to curb cancer cells in the immune system and are now pushing for a clinical ...

The researchers developed in tests using mice a method to stimulate weakened immune activity by restraining the cells restraining the immune response.

Courtesy Getty Images Maternal antibodies can cross the placenta at any time following alloimmunization, but it occurs mostly ...

AnaptysBio’s drug candidates rosnilimab and ANB032 hold key trial results ahead. Find out why ANAB stock is impacted by ...

Zanidatamab is the first agent approved specifically for advanced, HER2-positive second-line biliary tract cancer.

7 th Annual Evercore HealthCONx Conference Format: Fireside chat and one-on-one investor meetings Date: December 3, 2024 Time: 4:15 p.m. ET Webcast: Click here ...

In this GEN webinar, experts from WuXi AppTec will share essential strategies and methodologies for accelerating pre-clinical ...

Scientists have created a novel technology for developing antibody (M6P) conjugates without enzyme modification in vitro, ...

"The booster vaccine that we have in New Zealand at the moment is the XBB.1, I think, and that is still effective. And if we ...

As part of an international collaboration, Fred Hutch scientists provided structural information that helped reveal how two ...

We’re about six weeks out from when acute respiratory illness-related hospitalizations peaked in Illinois last year.